Boji Medical Technology Co.,Ltd.

Equities

300404

CNE100001Y00

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 23/05/2024 BST			5-day change	1st Jan Change
7.63 ^CNY	+0.13%		-2.55%	-14.75%

04-24	Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-08	Boji Medical Technology Inks 70 Million Yuan Technical Services Deal With Ruianbo Pharmaceutical Technology	MT

Guangzhou Boji Medical & Biotechnological Co., Ltd Approves Appointment of Liu Guochang as Independent Director

June 07, 2015

Guangzhou Boji Medical & Biotechnological Co., Ltd. announced at the extraordinary general meeting of 2015 held on June 05, 2015, the company approved the appointment of Liu Guochang as independent director.

Latest news about Boji Medical Technology Co.,Ltd.

Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Boji Medical Technology Inks 70 Million Yuan Technical Services Deal With Ruianbo Pharmaceutical Technology	04-08	MT
Boji Medical Technology's Unit Gets Nod to Market Erectile Dysfunction Tablets	03-12	MT
Tranche Update on Boji Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.	03-04	CI
Boji Medical Technology Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has closed with 2,667,000 shares, representing 0.72% for CNY 15.10 million.	02-29	CI
Boji Medical Technology Bags 107.7 Million Yuan Clinical Trial Assistance Deal; Shares Surge 20%	02-20	MT
Boji Medical Technology Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.	02-05	CI
Boji Medical Technology Co., Ltd. authorizes a Buyback Plan.	02-04	CI
Boji Medical Scores 54 Million Yuan Contract For Eye Drop Clinical Trial Research	01-26	MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23	CI
Boji Medical Technology Co., Ltd. Approves the Election of Directors and Non-Employee Supervisors	03/08/23	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Boji Medical Technology Gets Warning for Disclosure Breaches; Shares Jump 7%	28/02/23	MT
Boji Medical’s Chairman to Boost Stake to 39% After 84 Million Yuan Deal; Shares Rally 14%	16/02/23	MT
Boji Medical Technology Co., Ltd. announced that it expects to receive CNY 83.999999 million in funding	13/02/23	CI
Boji Medical Signs 55.5 Million Yuan Deal to Complete Trial of Therapeutic Drug	28/12/22	MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	25/04/22	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/04/22	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI
Guangzhou Boji Biomedical Science and Technology Park Co., Ltd. announced that it expects to receive CNY 30 million in funding from Boji Medical Technology Co., Ltd.	24/10/21	CI
Guangzhou Boji Medical & Biotechnological : Boji Medical Technology Adopts New Name	01/10/21	MT
Guangzhou Boji Medical & Biotechnological Co., Ltd. has Changed its Name to Boji Medical Technology Co., Ltd	30/09/21	CI

Chart Boji Medical Technology Co.,Ltd.

Duration

Period

More charts

Company Profile

Boji Medical Technology Co Ltd is a China-based company that provides Contract Research Organization (CRO) services. The Company mainly provides one-stop CRO services for the development and production of new drugs and medical devices for domestic and foreign pharmaceutical companies and other research institutions. The Company's CRO services include pre-clinical research services, clinical research services, other consulting services, pharmaceutical Contract Development Manufacture Organization (CDMO) services, pre-clinical independent research and development services, and technology achievement transformation services. The Company mainly conducts its businesses in the domestic market.

Sector

Biotechnology & Medical Research

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Boji Medical Technology Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.63 CNY

Average target price

11.74 CNY

Spread / Average Target

+53.87%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BOJI MEDICAL TECHNOLOGY CO.,LTD.	-14.75%	400M
MODERNA, INC.	+67.53%	63.85B
IQVIA HOLDINGS INC.	-0.77%	41.83B
LONZA GROUP AG	+45.66%	40.65B
CELLTRION, INC.	-10.72%	27.12B
ICON PUBLIC LIMITED COMPANY	+13.30%	26.52B
ALNYLAM PHARMACEUTICALS, INC.	-22.79%	18.69B
BIO-TECHNE CORPORATION	+4.70%	12.73B
UNITED THERAPEUTICS CORPORATION	+24.10%	12.11B
MEDPACE HOLDINGS, INC.	+27.41%	12.07B

Other Biotechnology & Medical Research